PROVIDENCE, R.I. (AP) - Rhode Island's major power company would be forced to buy renewable energy for a decade at a time under a bill proposed Thursday by Democrats in the state Senate.
Reporter Carla Garrett has been nominated for the Larry Smith Award for Novice Reporting (under 25,000 circulation) and sports editor Darryl Smart has been nominated for the London Free Press Award for Sports Photography (under 25,000 circulation).
Blackboard Inc. (NASDAQ: BBBB), a leading provider of enterprise technology for the education industry, today announces BbWorld(R) Commerce '08, a specialized users conference for Blackboard Commerce Suite(TM) clients. During the four-day conference, March 9th - 12th in Phoenix, AZ, more than 300 campus card and security professionals will gather to share insights and best practices on payment
Gov. Don Carcieri has reversed a cut to a Hasbro Children's Hospital program that allows sick children to keep up with schoolwork. Carcieri's budget proposal eliminated $100,000 from the Hasbro program-about 80 percent of its operating budget.
The R&S HF907 double-ridged waveguide horn antenna from Rohde & Schwarz improves accuracy in EMI and EMS measurements. The unique, modified design of its housing ensures high and flat gain from 5 dBi to 14 dBi without any gain losses
H&R Block Inc , the largest U.S. tax preparer, reported a smaller quarterly loss as higher revenue from tax returns helped offset costs for job cuts and the closing of a money-losing subprime mortgage unit.
HANOVER, Md.----Conmed Healthcare Management, Inc. , a leading full service provider of correctional facility healthcare services to county detention centers, today announced that Brian R.
Cortex Pharmaceuticals, Inc. (AMEX: COR, http://www.cortexpharm.com), has received approval from the German Federal Institute For Drugs And Medical Devices (BfArM) to initiate two AMPAKINE(R) CX717 clinical studies. These studies will assess whether the pre-administration of CX717 can prevent the development of respiratory depression (RD) induced by the potent Schedule II opiate agonist,